110 Startups
  • Sector
  • Participated in
  • Year of participation

Sella Therapies

  • 2021
  • Medical Device
  • Therapeutics
  • Venture Challenge
Sella Therapies is a clinical-stage medical device company developing a novel therapy for chronic pain relief that targets the body’s internal neuropeptide system.

Sencilia

  • 2023
  • Medical Device
  • Venture Challenge
Sencilia has developed a first-of-its-kind flow sensing device to reduce medication errors due to flow instabilities in intravenous infusions in neonates.

SeraNovo

  • 2018
  • Enabling Technology
  • Venture Challenge
SeraNovo’s proprietary formulation platform radically increases bioavailability and allows products to reach the market significantly quicker, at a lower cost.

ShanX Medtech

  • 2020
  • Diagnostics
  • Venture Challenge
Providing a reliable UTI diagnosis and simultaneously indicating the optimal antibiotic prescription in under 4 hours

SimpleXable

  • 2022
  • Enabling Technology
  • Venture Challenge
Simplexable provides three-dimensional human scar models that are suitable for high content screening of compounds, targeting key events of hypertrophic scar formation.

Sirius Medical

  • 2015
  • Medical Device
  • Venture Challenge
The next generation of accurate and hassle-free tumor localization for breast cancer.

SLAM Orthopedic

  • 2020
  • Medical Device
  • Venture Challenge
SLAM Ortho has developed an automated, accurate and fast bore depth measurement system for use in orthopaedic trauma procedures for fractures in extremities

Spatium Medical

  • 2023
  • Medical Device
  • Venture Challenge
Spatium Medical introduces the world’s first medical insufflator that ensures stable workspace at lowest insufflation and ventilation pressure with three patented technologies addressing three unmet needs.

STENTiT

  • 2016
  • Medical Device
  • Venture Challenge
To become the new standard in vascular treatment. By bringing regenerative capacity for the first time to a stent, a wide range of clinical applications will benefit from our innovative approach.

T-Cell Factory

  • 2013
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
T Cell Factory (TCF) will identify and develop therapeutic T cell receptor (TCR) genes for the growing market of cancer therapies.